Apollomics, Inc. (NASDAQ:APLMW) Short Interest Down 38.9% in February

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 4,400 shares, a decrease of 38.9% from the January 31st total of 7,200 shares. Based on an average daily volume of 64,200 shares, the days-to-cover ratio is presently 0.1 days.

Apollomics Price Performance

Shares of NASDAQ APLMW remained flat at $0.01 during midday trading on Tuesday. The company had a trading volume of 13,100 shares, compared to its average volume of 23,508. Apollomics has a 52-week low of $0.01 and a 52-week high of $0.03. The company’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.